ITGA5 and neoplasm: There is mounting evidence highlighting a role for ITGA5 in tumor progression, tumor metastasis, and therapy resistance across several malignancies including glioblastoma, colorectal carcinoma, pancreatic cancer, cervical cancer, and non-small cell lung carcinoma [24–30].